In the field of biomanufacturing, the challenge of host cell protein (HCP) purification remains a critical hurdle in many biotherapeutic...
Effective Strategies for Host Cell Protein Purification: A Case Study
read more
Is your commercial HCP ELISA assay suitable to secure your bioprocess?
In early stages of biotherapeutic development, generic HCP ELISA are an easy-to-use solution to quantify HCP content in DS and show HCP...
GTP Technology adds trained Biosafety Officer to expert team
GTP's BSO assists technical leaders, assesses risks and is key to the implementation and continued application of a full-fledged biosafety...
The right QC development process & subcontractor for your project
The best way for biotech companies to address the analytical development of their biotherapeutic candidates at preclinical and clinical...
Glycan characterization of proteins during process development
Our partner PROTEODYNAMICS, a glycan analysis and protein characterization expert, reviews the relevant methods to characterise the...
Tackling challenges in host cell protein analysis for biologics
IDBiotech, an ELISA development specialist, explains why the quantification of HCPs is a key point in CMC strategy. HCPs are proteins...
How to choose a method for protein size analysis (and why the sky is blue)
The size of a protein is an important physical characteristic that provides useful information on oligomeric state, on protein aggregation...
